Relationship between timing of trial randomization, protocol completion, and clinical outcomes among patients hospitalized for heart failure: from the ASTRONAUT trial-Reference-Cited by-同舟云学术

Relationship between timing of trial randomization, protocol completion, and clinical outcomes among patients hospitalized for heart failure: from the ASTRONAUT trial

Published:2018-11-11 Issue:12 Volume:20 Page:1760-1763
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Greene Stephen J.¹,Fonarow Gregg C.²,Solomon Scott D.³,Subacius Haris P.⁴,Vaduganathan Muthiah³,Ambrosy Andrew P.⁵⁶,Fudim Marat¹,Böhm Michael⁷,Maggioni Aldo P.⁸,Lewis Eldrin F.³,Zannad Faiez⁹,Butler Javed¹⁰

Affiliation:

1. Duke Clinical Research Institute and Division of CardiologyDuke University School of Medicine Durham NC USA

2. Ahmanson‐UCLA Cardiomyopathy CenterUniversity of California Los Angeles Los Angeles CA USA

3. Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical Center Boston MA USA

4. Center for Cardiovascular InnovationNorthwestern University Feinberg School of Medicine Chicago IL USA

5. Division of CardiologyThe Permanente Medical Group San Francisco, CA USA

6. Division of ResearchKaiser Permanente Northern California Oakland, CA USA

7. Klinik für Innere Medizin IIIUniversitätsklinikum des Saarlandes Homburg Germany

8. Italian Association of Hospital Cardiologists (ANMCO) Research Center Florence Italy

9. Centre d'Investigation Clinique Plurithématique 1433, INSERM U1116Université de Lorraine CHRU de Nancy, Nancy France

10. Department of MedicineUniversity of Mississippi Jackson MS USA

Funder

Novartis Pharma

Feinberg School of Medicine

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1310

Reference9 articles.

1. Clinical trials in acute heart failure: beginning of the end or end of the beginning?

2. Past, present, and future of acute heart failure clinical trials-a high-risk population in search of a strategy

3. Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure

4. Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT)

5. Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart FailureThe EVEREST Outcome Trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pragmatic Design of Randomized Clinical Trials for Heart Failure;JACC: Heart Failure;2021-05